Rasha Youssef
Family Medicine · Boynton Beach, FLNPI 1154376648
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.8% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,149, 2.4 times the $485 reported in 2019.
Across 39 payments — averaging $116.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$738
- AstraZeneca$703
- Boehringer Ingelheim$658
- Bayer$589
- Johnson & Johnson$448
- Silk Road Medical, Inc.$187
- plus $1K from 9 others
Across 915 payments — averaging $8126.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2.4M
- Janssen Research & Development, LLC$2M
- Boehringer Ingelheim International GmbH$1.2M
- Boehringer Ingelheim$541K
- F. Hoffmann-la Roche AG$315K
- Novartis$217K
- plus $832K from 13 others
What the payments were for
- Travel & lodging$2816%
- Food & beverage$4,24594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 6 | $738 |
| AstraZeneca | 6 | $703 |
| Boehringer Ingelheim | 6 | $658 |
| Bayer | 6 | $589 |
| Johnson & Johnson | 4 | $448 |
| Silk Road Medical, Inc. | 1 | $187 |
| Novo Nordisk | 2 | $181 |
| Shockwave Medical, Inc | 1 | $140 |
| Atricure, Inc. | 1 | $136 |
| Abbott | 1 | $135 |
| Novartis | 1 | $125 |
| Lilly USA, LLC | 1 | $124 |
| Boston Scientific | 1 | $122 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Pfizer | 1 | $116 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$738
- FARXIGA$494
- Kerendia$481
- XARELTO$448
- ENROUTE Transcarotid Neuroprotection System$187
- ENROUTE Transcarotid Stent$187
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$140
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$136
- Confirm Rx$135
- ENTRESTO$125
- ZEPBOUND$124
- JARDIANCE$123
- Watchman$122
- AMVUTTRA$122
- BRILINTA$116
- VYNDAQEL$116
How this compares
$4,527 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Boynton Beach
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.